Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Massarella

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Pharmacokinetics|January 11, 2000
Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802G He, J Massarella, P Ward
Journal of Pharmaceutical Sciences|September 1, 1986
Relative and absolute bioavailability of cibenzoline capsules and tablets in healthy subjectsJ Massarella, T Silvestri, A Lin
British Journal of Clinical Pharmacology|January 1, 1989
The pharmacokinetics and dose proportionality of cilazaprilJ Massarella, T DeFeo, A Lin, et al.
American Journal of Obstetrics and Gynecology|March 1, 1996
Mechanism and rate of placental transfer of zalcitabine (2',3'-dideoxycytidine) in Macaca nemestrinaT Tuntland, C Nosbisch, W L Baughman, et al.
Journal of Clinical Pharmacology|May 23, 1998
The effects of renal impairment on the pharmacokinetics of zalcitabineM Bazunga, H T Tran, H Kertland, et al.
Clinical Pharmacology and Therapeutics|April 1, 1985
Etretinate kinetics during chronic dosing in severe psoriasisJ Massarella, F Vane, C Buggé, et al.
The Journal of Pediatrics|December 5, 1997
Safety and efficacy of flumazenil in the reversal of benzodiazepine-induced conscious sedation. The Flumazenil Pediatric Study GroupM Shannon, G Albers, K Burkhart, et al.
Journal of Clinical Pharmacology|January 1, 1991
Bioavailability and kinetics of cibenzoline in patients with normal and impaired renal functionG Aronoff, M Brier, M L Mayer, et al.
British Journal of Clinical Pharmacology|February 12, 1998
Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjectsJ M van Gerven, G Roncari, R C Schoemaker, et al.
British Journal of Clinical Pharmacology|February 12, 1998
Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjectsJ Dingemanse, J M van Gerven, R C Schoemaker, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Pharmacokinetics|January 11, 2000
Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802G He, J Massarella, P Ward
Journal of Pharmaceutical Sciences|September 1, 1986
Relative and absolute bioavailability of cibenzoline capsules and tablets in healthy subjectsJ Massarella, T Silvestri, A Lin
British Journal of Clinical Pharmacology|January 1, 1989
The pharmacokinetics and dose proportionality of cilazaprilJ Massarella, T DeFeo, A Lin, et al.
American Journal of Obstetrics and Gynecology|March 1, 1996
Mechanism and rate of placental transfer of zalcitabine (2',3'-dideoxycytidine) in Macaca nemestrinaT Tuntland, C Nosbisch, W L Baughman, et al.
Journal of Clinical Pharmacology|May 23, 1998
The effects of renal impairment on the pharmacokinetics of zalcitabineM Bazunga, H T Tran, H Kertland, et al.
Clinical Pharmacology and Therapeutics|April 1, 1985
Etretinate kinetics during chronic dosing in severe psoriasisJ Massarella, F Vane, C Buggé, et al.
The Journal of Pediatrics|December 5, 1997
Safety and efficacy of flumazenil in the reversal of benzodiazepine-induced conscious sedation. The Flumazenil Pediatric Study GroupM Shannon, G Albers, K Burkhart, et al.
Journal of Clinical Pharmacology|January 1, 1991
Bioavailability and kinetics of cibenzoline in patients with normal and impaired renal functionG Aronoff, M Brier, M L Mayer, et al.
British Journal of Clinical Pharmacology|February 12, 1998
Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjectsJ M van Gerven, G Roncari, R C Schoemaker, et al.
British Journal of Clinical Pharmacology|February 12, 1998
Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjectsJ Dingemanse, J M van Gerven, R C Schoemaker, et al.
Pageof 1